Crossref
Therapeutic targeting of SATB2 for treating hepatocellular carcinoma
European Journal of Cancer · 2026-11 · 248 · 118164
DOI: 10.1016/j.ejca.2026.118164 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von K. Pandav und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pandav, K., Srivastava, S., Ahmed, Z., Landry, N., Shrivastava, A., & Srivastava, R. (2026). Therapeutic targeting of SATB2 for treating hepatocellular carcinoma. European Journal of Cancer, 248, 118164. https://doi.org/10.1016/j.ejca.2026.118164
Vancouver
Pandav K, Srivastava S, Ahmed Z, Landry N, Shrivastava A, Srivastava R. Therapeutic targeting of SATB2 for treating hepatocellular carcinoma. European Journal of Cancer. 2026;248:118164. doi:10.1016/j.ejca.2026.118164
BibTeX
@article{Pandav2026,
author = {Pandav, K. and Srivastava, S. and Ahmed, Z. and Landry, N. and Shrivastava, A. and Srivastava, R.},
title = {Therapeutic targeting of SATB2 for treating hepatocellular carcinoma},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {118164},
doi = {10.1016/j.ejca.2026.118164}
}
EUVIMED